CVC Capital Partners has announced that it is no longer in discussions with listed trust and corporate management services firm Intertrust about a potential public offer and combination with portfolio company TMF Group.
Secondary buyout sees San-Francisco-based GP pre-empt auction for Italian generic drugmaker
GP makes series of promotions and appointments following GBP 2.5bn fundraising earlier this year
Enact III is more than three times the size of its predecessor fund, which closed on GBP 30m in 2019
Andre Retterath and Paul Klemm are existing team members, while Vincenzo Narciso joins from Px3 Partners